Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a clinical-stage biotechnology company developing

Interim analysis to be conducted under an FDA- and EMA-agreed protocolRamat Gan, Israel, July 06, 20

Gainers Chemomab Therapeutics (NASDAQ:CMMB) stock increased by 33.8% to $2.27 during Thursday's

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Can Fite Biopharma (AMEX:CANF)

Gainers Can Fite Biopharma (AMEX:CANF) shares rose 43.8% to $4.27 during Wednesday's regular se

Can-Fite's Phase 2a Namodenoson study met its safety endpoint and showed durable survival, suppo

Gainers Can Fite Biopharma (AMEX:CANF) stock moved upwards by 52.0% to $4.52 during Wednesday's

NKE: -9% | Nike shares are trading lower. The company reported Q4 financial results. BE: 12% | Bloom

Gainers Universe Pharmaceuticals (NASDAQ:UPC) stock moved upwards by 168.2% to $7.94 during Friday&

Can-Fite stock rises after Japan patent allowance strengthens Namodenoson’s obesity and metabolic di

Gainers Quantum Cyber (NASDAQ:QUCY) stock moved upwards by 63.4% to $2.37 during Friday's pre-m

ON: -14% | ON stock has given up its prior gain. ON Semiconductor shares were trading higher after t

The allowed Patent strengthens protection in one of the world's largest pharmaceutical markets a

Can-Fite BioPharma Ltd. (NYSE:CANF) (TASE: CANF), a biotechnology company advancing a pipeline of pr

U.S. stocks up on Wednesday with NASDAQ gaining 0.85%. ISM services PMI rose to 56.1. VCI Global Ltd

US stocks rise, with Dow up 0.25% and NASDAQ up 0.69%. Consumer discretionary shares increase by 1.1

U.S. stock futures slightly lower. UiPath joins S&P Midcap 400, Agios receives FDA approval, Can

  On Friday morning, 446 companies hit new 52-week lows.

    Tuesday's session saw 729 companies set new 52-week lows.